Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B Return on Equity

Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B (BDXB) currently reports a ROE of 4.62%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's ROE history and peer comparisons.

Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's ROE of 4.62% is lower than the Healthcare sector average of 29.33%. That is roughly 84.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B's current 4.62% should be judged against Healthcare norms (sector average: 29.33%) and against BDXB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 4.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B, and consider following BDXB for alerts when major investors trade the stock.

Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B is classified in the Healthcare sector. On ROE, it currently shows 4.62% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BDXB with unrelated industries.